Here, we revealed DMS-low subtype was characterized as CIMP positive, mutant BRAF, MSI, and higher TMB, indicating this epigenotype of colon cancer identified by DMS had specific molecular alterations. This evidence concerns the gene BRAF and malignant colon neoplasm.